Efficacy of Lycopene in the Treatment of Oral Submucous Fibrosis: A Meta-analysis of Randomized Controlled Trials
Jincai Guo,Hui Xie,Hao Wu,Mining Liang
DOI: https://doi.org/10.1016/j.jebdp.2020.101471
IF: 5.1
2020-12-01
Journal of Evidence Based Dental Practice
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objectives</h3><p>The aim of this meta-analysis was to systematically evaluate the efficacy of lycopene in improving maximum mouth opening and other clinical symptoms in patients with oral submucous fibrosis (OSF).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>We searched five databases: PubMed, Web of Science, Embase, The Cochrane Library, and EBSCO. Randomized controlled trials were collected to evaluate the efficacy of lycopene in the treatment of OSF. Each database was searched from inception to 30 April 2019. RevMan 5.3 software was used for this meta-analysis.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>The included studies were 7 randomized controlled trials involving 758 patients with OSF. The results of this meta-analysis showed that lycopene was significantly more effective in improving maximum mouth opening in OSF patients than placebo treatment (mean difference [MD]: 3.15; 95% confidence interval [CI]: 2.19–4.10, P < 0.0001, I<sup>2</sup>=0%). As compared with control groups, Lycopene could significantly increase the maximum mouth opening in OSF patients after one month treatment (MD, 2.40; 95% CI, 2.22–2.58; P =0.91; I<sup>2</sup>=0%) , two months treatment(MD, 3.19; 95% CI, 2.87–3.51; P =0.93; I<sup>2</sup>=0%) and three months treatment (MD, 4.89; 95% CI, 4.51–5.28; P =0.86; I<sup>2</sup>=0%). However, no significant difference was found in alleviation of burning sensation after one month (RR, 1.04; 95% CI, 0.89–1.23; P =0.73; I<sup>2</sup>=0%), after two months (RR, 0.98; 95% CI, 0.73–1.31; P =0.69; I<sup>2</sup>=0%) and after three months treatment (RR, 0.84; 95% CI, 0.47–1.52; P =0.81; I<sup>2</sup>=0%); tongue protrusion (MD, -1.59; 95% CI, -4.15–0.97; P =0.12; I<sup>2</sup>=58%); and pain associated with the lesion after one month (RR, 1.05; 95% CI, 0.92–1.21; P =0.77; I<sup>2</sup>=0%), after two months (RR, 0.95; 95% CI, 0.75–1.19; P =0.35; I<sup>2</sup>=0%) and after three months (RR, 0.95; 95% CI, 0.68–1.33; P =0.14; I<sup>2</sup>=51%) in OSF patients between lycopene and control groups.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>The results of this meta-analysis showed that lycopene is more effective for improving symptoms of maximum mouth opening than placebo groups and control groups, but there were no significant difference in burning sensation, pain associated with lesion and tongue protrusion in OSF patients compared with control groups.</p>
dentistry, oral surgery & medicine